Fundraising Fox

Novira Therapeutics

Doylestown, US · 4 known investors

Biotech

Founders & leadership

AF
Anthony Ford-HutchinsonNamed on SEC filing
DE
Daniel E. GeffkenNamed on SEC filing
TS
Tim ShannonNamed on SEC filing
OF
Osvaldo FloresNamed on SEC filing
GH
George HartmanNamed on SEC filing
GK
Gregory KorbelNamed on SEC filing
SR
Scott RocklageNamed on SEC filing
GG
Gianni GromoNamed on SEC filing

Investors · 4

BioAdvanceConshohocken · $500K – $1.5M
Canaan PartnersStamford · $500K – $20M
5AM VenturesreportedBoston · $100K – $4M
Versant VenturesreportedSan Francisco · $250K – $5M

Reported raises · per SEC filings

Form D private placements

$37M disclosed across 2 rounds · 2012–2014

▶$9MraisedDec 2014 · 10 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott M. RocklageDirector
  • Tim ShannonDirector
  • Christian S. SchadeExecutive Officer, Director
  • Nathaniel BrownExecutive Officer
  • Anthony Ford-HutchinsonDirector
  • Gianni GromoDirector
  • Osvaldo FloresExecutive Officer
  • George HartmanExecutive Officer
  • Klaus KlumppExecutive Officer
  • Douglas CarrExecutive Officer
Offering amount
$9M
Amount sold
$9M
Proceeds to insiders
$1.3M
First sale
Dec 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$28MraisedFeb 2014 · 10 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Anthony Ford-HutchinsonDirector
  • Daniel E. GeffkenExecutive Officer
  • Tim ShannonDirector
  • Osvaldo FloresExecutive Officer, Director
  • George HartmanExecutive Officer
  • Gregory KorbelExecutive Officer
  • Scott RocklageDirector
  • Gianni GromoDirector
Offering amount
$29.8M
Amount sold
$28M
Minimum investment
$58.2K
Proceeds to insiders
$700K
First sale
Aug 2012
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Novira Therapeutics went on to found or lead other companies.

Christian SchadeChief Executive OfficerFounded Halda Therapeutics +1Kush M ParmarBoard Observer and Acting VP, Strategy and Corporate DevelopmentFounded Homology Medicines

In the news

Novira Therapeutics Completes $25 Million Series A Financingprnewswire.com · Mar 2013Novira Therapeutics Secures $7.5M; Completes $25M Series A Financing - FinSMEsfinsmes.com · Mar 2013Novira Therapeutics Secures $23 Million Series A Financing to Advance Antiviral Research - BioSpacebiospace.com · Aug 2012Novira Therapeutics Completes Second Round of Seed Financing - FinSMEsfinsmes.com · Jul 2011Novira Therapeutics Gets Seededventurecapitaljournal.com · Mar 2009

Frequently asked questions

Who are Novira Therapeutics's investors?
Novira Therapeutics's investors include BioAdvance, Canaan Partners, 5AM Ventures, Versant Ventures.
How much funding has Novira Therapeutics raised?
Novira Therapeutics has disclosed $37M raised across 2 rounds.
Where is Novira Therapeutics headquartered?
Novira Therapeutics is headquartered in Doylestown, US.